U.S. Shuts Down Risky Novel Animal Virus Research Program
The U.S. government has shut down a research program that searches for new animal viruses in Asia, Africa and Latin America that have the potential to infect humans and cause a pandemic. The $125 million dollar research program called Discovery and Exploration of Emerging Pathogens- Viral Zoonoses (DEEP VZN) focused on the study of novel […]
Pulling Out All the Stops to Sell More COVID Shots
This year, Pfizer, Inc. and Moderna, Inc. have experienced sharply declining sales of their messenger RNA (mRNA) COVID-19 shots, Comirnaty and Spikevax. Pfizer reported first-quarter (ending Mar. 31, 2023) sales of $3 billion for Comirnaty—down 75 percent from the same period in 2022. It posted second-quarter (ending June 30) sales of $1.49 billion—down 83 percent […]
Big Pharma’s Revolving Door With Government Health Agencies
More than half of the staff at the U.S. Centers for Disease Control and Prevention (CDC) go to work for pharmaceutical giants when they leave the government, according to a new report by researchers at the University of Southern California and Harvard University. The report showed that eight percent of the CDC staff came from […]
Sleep Crisis Affects Mental Health of Students in U.S.
At least 50 percent of middle school students and 75 percent of high school students in the United States are not getting enough hours of sleep on a daily basis, according to the U.S. Centers for Disease Control and Prevention (CDC).1 Commenting on children not getting enough sleep, Oleg Tarkovsky, director of Behavioral Health Services […]
Private Equity Buyouts of Health Care Facilities Comes With Cost to Patients
The rising trend in burnout of health care workers in recent years has presented an opportunity for private equity corporations in the United States to invest in the health care market at record high rates.1 For several decades, multibillion-dollar corporate giants have been gaining control of many sectors of American society, including the food industry […]
Federal Court Sides With Doctors on Ivermectin Lawsuit Charging FDA Overreach
The Fifth Circuit Court of Appeals in New Orleans has given new life to a lawsuit brought by three doctors claiming the U.S. Food and Drug Administration (FDA) overstepped its authority and acted as a medical doctor rather than as a regulating authority in the agency’s campaign promoting a ban on the use of the […]